Sandoz Drug Patent Portfolio

Sandoz owns 21 orange book drugs protected by 65 US patents with Argatroban having the least patent protection, holding only 1 patent. And Focalin Xr with maximum patent protection, holding 8 patents. Given below is the list of Sandoz's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8268299 Self preserved aqueous pharmaceutical compositions 13 Oct, 2029
Active
US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jan, 2029
Active
US7598343 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jan, 2029
Active
US7932241 Pharmaceutical products comprising bisphosphonates 05 Aug, 2028
Active
US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jul, 2028
Active
US7598343 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jul, 2028
Active
US7932241 Pharmaceutical products comprising bisphosphonates 05 Feb, 2028
Active
US8323630 Self-preserved aqueous pharmaceutical compositions 20 Sep, 2027
Active
US8388941 Self preserved aqueous pharmaceutical compositions 20 Sep, 2027
Active
US7265117 Topical brimonidine tartrate formulations that lack chlorine dioxide 19 Aug, 2025
Active
US8846650 Method of treating middle ear infections 04 Jun, 2025
Active
US8158645 Compound, corresponding compositions, preparation and/or treatment methods 10 Dec, 2024
Active
US8052987 Method of administering bisphosphonates 27 Oct, 2023 Expired
US9149486 Method of treating middle ear infections 13 Sep, 2022 Expired
US9345714 Method of treating middle ear infections 13 Sep, 2022 Expired
US9402805 Method of treating middle ear infections 13 Sep, 2022 Expired
US6242003 Organic compounds 13 Oct, 2020 Expired
US6284804 Topical suspension formulations containing ciprofloxacin and dexamethasone 10 Aug, 2020 Expired
US6359016 Topical suspension formulations containing ciprofloxacin and dexamethasone 10 Aug, 2020 Expired
US6242003 Organic compounds 13 Apr, 2020 Expired
US6114319 Compositions containing difluprednate 18 Nov, 2019 Expired
US6228398 Multiparticulate modified release composition 01 Nov, 2019 Expired
US6730325 Multiparticulate modified release composition 01 Nov, 2019 Expired
US6174524 Gelling ophthalmic compositions containing xanthan gum 26 Sep, 2019 Expired
US6114319 Compositions containing difluprednate 18 May, 2019 Expired
US6174524 Gelling ophthalmic compositions containing xanthan gum 26 Mar, 2019 Expired
US6316023 TTS containing an antioxidant 08 Jan, 2019 Expired
US6335031 TTS containing an antioxidant 08 Jan, 2019 Expired
US6162802 Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor 19 Dec, 2017 Expired
US5424295 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine 13 Jun, 2017 Expired
US5854270 Oral compositions containing ondansetron 20 May, 2016 Expired
US5955488 Freeze-dried compositions 14 May, 2016 Expired
US6063802 Ondansetron freeze-dried dosage form compositions for oral administration 14 May, 2016 Expired
US5908850 Method of treating attention deficit disorders with d-threo methylphenidate 04 Dec, 2015 Expired
US6355656 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015 Expired
US6528530 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015 Expired
US5837284 Delivery of multiple doses of medications 04 Dec, 2015 Expired
US6635284 Delivery of multiple doses of medications 04 Dec, 2015 Expired
US7431944 Delivery of multiple doses of medications 04 Dec, 2015 Expired
US5854270 Oral compositions containing ondansetron 20 Nov, 2015 Expired
US5955488 Freeze-dried compositions 14 Nov, 2015 Expired
US6063802 Ondansetron freeze-dried dosage form compositions for oral administration 14 Nov, 2015 Expired
US5196404 Inhibitors of thrombin 15 Jun, 2015 Expired
US5843930 Method of treating otitis with ciprofloxacin-hydrocortisone suspension 06 Jun, 2015 Expired
US5965549 Ciprofloxacin-hydrocortisone suspension 06 Jun, 2015 Expired
US5674872 Treatment of ovarian cancer 07 Apr, 2015 Expired
US5196404 Inhibitors of thrombin 15 Dec, 2014 Expired
US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension 02 Dec, 2014 Expired
US5674872 Treatment of ovarian cancer 07 Oct, 2014 Expired
US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Aug, 2014 Expired
US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them 30 Jun, 2014 Expired
US5602176 Phenyl carbamate 11 Feb, 2014 Expired
US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration 07 Jan, 2014 Expired
US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension 03 Aug, 2013 Expired
US5461081 Topical ophthalmic pharmaceutical vehicles 24 Apr, 2013 Expired
US4939130 Substituted alkanediphosphonic acids and pharmaceutical use 02 Mar, 2013 Expired
US5492897 Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives 20 Feb, 2013 Expired
US5747472 Therapeutic methods for using ARA-G derivatives 20 Feb, 2013 Expired
US5821236 Tumor treatment with arabinofuranosyl purine derivatives 20 Feb, 2013 Expired
US5474783 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012 Expired
US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012 Expired
US5461081 Topical ophthalmic pharmaceutical vehicles 24 Oct, 2012 Expired
US5378703 Sulfonamides useful as carbonic anhydrase inhibitors 01 Oct, 2012 Expired
US4939130 Substituted alkanediphosphonic acids and pharmaceutical use 02 Sep, 2012 Expired
US4948807 Phenyl carbamates 14 Aug, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Sandoz.

Activity Date Patent Number
Patent litigations
Expire Patent 01 Jul, 2024 US9345714
Payment of Maintenance Fee, 12th Year, Large Entity 22 May, 2024 US8323630 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 06 Mar, 2024 US8268299 (Litigated)
Maintenance Fee Reminder Mailed 15 Jan, 2024 US9345714
Expire Patent 13 Nov, 2023 US9149486
Payment of Maintenance Fee, 12th Year, Large Entity 04 Oct, 2023 US8158645
Maintenance Fee Reminder Mailed 29 May, 2023 US9149486
Payment of Maintenance Fee, 12th Year, Large Entity 26 Apr, 2023 US8052987 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 16 Mar, 2022 US8846650
Payment of Maintenance Fee, 12th Year, Large Entity 24 Mar, 2021 US7598343 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 17 Feb, 2021 US7582727
Payment of Maintenance Fee, 8th Year, Large Entity 21 Aug, 2020 US8388941
Payment of Maintenance Fee, 8th Year, Large Entity 21 May, 2020 US8323630 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 05 Mar, 2020 US8268299 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 23 Jan, 2020 US9402805


Sandoz's Drug Patent Litigations

Sandoz's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Apr 14, 1994, against patent number US6162802. The petitioner , challenged the validity of this patent, with PAPA et al as the respondent. Click below to track the latest information on how companies are challenging Sandoz's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8268299 March, 2017 FWD Entered
(20 Sep, 2018)
Alcon Research, Ltd. Argentum Pharmaceuticals LLC
US6114319 May, 2015 FWD Entered
(22 Nov, 2016)
SENJU PHARMACEUTICAL CO., LTD Akorn, Inc.
US6316023 April, 2014 FWD Entered
(28 Sep, 2015)
Novartis AG Noven Pharmaceuticals, Inc.
US6316023 November, 2014 FWD Entered
(28 Sep, 2015)
Novartis AG Mylan Pharmaceuticals Inc.
US6335031 April, 2014 FWD Entered
(28 Sep, 2015)
Novartis AG Noven Pharmaceuticals, Inc.
US6335031 November, 2014 FWD Entered
(28 Sep, 2015)
Novartis AG Mylan Pharmaceuticals Inc.
US8268299 July, 2013 Terminated-Settled
(21 Jul, 2014)
ALCON RESEARCH, LTD. Apotex Corp.
US8323630 July, 2013 Terminated-Settled
(21 Jul, 2014)
ALCON RESEARCH, LTD. Apotex Corp.
US8388941 July, 2013 Terminated-Settled
(21 Jul, 2014)
Alcon Research, Ltd. Apotex Corp.
US6162802 April, 1994 Decision
(04 Jul, 1776)
PAPA et al


Sandoz Drug Patents' Oppositions Filed in EPO

Sandoz drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 21, 2006, by Strawman Limited. This opposition was filed on patent number EP02799587A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP07842925A Mar, 2016 Pohlman, Sandra M. Patent maintained as amended
EP05012711A Jun, 2013 Taylor Wessing LLP Revoked
EP05012711A Jun, 2013 Sanovel IIaç San. ve Tic. A.S. Revoked
EP05012711A Jun, 2013 Teva Pharmaceutical Industries LTD. Revoked
EP05012711A Jun, 2013 Actavis PTC ehf Revoked
EP05012711A Mar, 2013 Generics [UK] Limited Revoked
EP07842914A Aug, 2012 Pohlman, Sandra M. Patent maintained as amended
EP07842914A Aug, 2012 ALLERGAN, INC. Patent maintained as amended
EP02799587A Sep, 2006 STRAWMAN LIMITED Opposition rejected


Sandoz's Family Patents

Sandoz drugs have patent protection in a total of 38 countries. It's US patent count contributes only to 20.6% of its total global patent coverage. 15 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sandoz Drug List

Given below is the complete list of Sandoz's drugs and the patents protecting them.


1. Angiomax

Angiomax is protected by 6 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7582727
(Pediatric)
Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jan, 2029
(4 years from now)
Active
US7598343
(Pediatric)
Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jan, 2029
(4 years from now)
Active
US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jul, 2028
(3 years from now)
Active
US7598343 Pharmaceutical formulations of bivalirudin and processes of making the same 27 Jul, 2028
(3 years from now)
Active
US5196404
(Pediatric)
Inhibitors of thrombin 15 Jun, 2015
(9 years ago)
Expired
US5196404 Inhibitors of thrombin 15 Dec, 2014
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Angiomax's drug page


2. Argatroban

Argatroban is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them 30 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Argatroban's drug page


3. Arranon

Arranon is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5424295 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine 13 Jun, 2017
(7 years ago)
Expired
US5492897 Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives 20 Feb, 2013
(11 years ago)
Expired
US5747472 Therapeutic methods for using ARA-G derivatives 20 Feb, 2013
(11 years ago)
Expired
US5821236 Tumor treatment with arabinofuranosyl purine derivatives 20 Feb, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arranon's drug page


4. Azopt

Azopt is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5461081
(Pediatric)
Topical ophthalmic pharmaceutical vehicles 24 Apr, 2013
(11 years ago)
Expired
US5461081 Topical ophthalmic pharmaceutical vehicles 24 Oct, 2012
(11 years ago)
Expired
US5378703
(Pediatric)
Sulfonamides useful as carbonic anhydrase inhibitors 01 Oct, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azopt's drug page


5. Ciprodex

Ciprodex is protected by 6 patents, out of which 5 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8846650 Method of treating middle ear infections 04 Jun, 2025
(7 months from now)
Active
US9149486 Method of treating middle ear infections 13 Sep, 2022
(2 years ago)
Expired
US9345714 Method of treating middle ear infections 13 Sep, 2022
(2 years ago)
Expired
US9402805 Method of treating middle ear infections 13 Sep, 2022
(2 years ago)
Expired
US6284804 Topical suspension formulations containing ciprofloxacin and dexamethasone 10 Aug, 2020
(4 years ago)
Expired
US6359016 Topical suspension formulations containing ciprofloxacin and dexamethasone 10 Aug, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ciprodex's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Cipro Hc

Cipro Hc is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5843930 Method of treating otitis with ciprofloxacin-hydrocortisone suspension 06 Jun, 2015
(9 years ago)
Expired
US5965549 Ciprofloxacin-hydrocortisone suspension 06 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cipro Hc's drug page


7. Durezol

Durezol is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6114319
(Pediatric)
Compositions containing difluprednate 18 Nov, 2019
(4 years ago)
Expired
US6114319 Compositions containing difluprednate 18 May, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Durezol's drug page


8. Exelon

Exelon is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6316023 TTS containing an antioxidant 08 Jan, 2019
(5 years ago)
Expired
US6335031 TTS containing an antioxidant 08 Jan, 2019
(5 years ago)
Expired
US5602176 Phenyl carbamate 11 Feb, 2014
(10 years ago)
Expired
US4948807 Phenyl carbamates 14 Aug, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exelon's drug page


9. Focalin

Focalin is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5908850 Method of treating attention deficit disorders with d-threo methylphenidate 04 Dec, 2015
(8 years ago)
Expired
US6355656 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015
(8 years ago)
Expired
US6528530 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Focalin's drug page


10. Focalin Xr

Focalin Xr is protected by 8 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6228398 Multiparticulate modified release composition 01 Nov, 2019
(4 years ago)
Expired
US6730325 Multiparticulate modified release composition 01 Nov, 2019
(4 years ago)
Expired
US5837284 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired
US5908850 Method of treating attention deficit disorders with d-threo methylphenidate 04 Dec, 2015
(8 years ago)
Expired
US6355656 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015
(8 years ago)
Expired
US6528530 Phenidate drug formulations having diminished abuse potential 04 Dec, 2015
(8 years ago)
Expired
US6635284 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired
US7431944 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Focalin Xr's drug page


11. Hycamtin

Hycamtin is protected by 3 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8158645 Compound, corresponding compositions, preparation and/or treatment methods 10 Dec, 2024
(a month from now)
Active
US5674872
(Pediatric)
Treatment of ovarian cancer 07 Apr, 2015
(9 years ago)
Expired
US5674872 Treatment of ovarian cancer 07 Oct, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hycamtin's drug page


12. Lescol Xl

Lescol Xl is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6242003
(Pediatric)
Organic compounds 13 Oct, 2020
(4 years ago)
Expired
US6242003 Organic compounds 13 Apr, 2020
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lescol Xl's drug page


13. Lotrel

Lotrel is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6162802 Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor 19 Dec, 2017
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lotrel's drug page


14. Qoliana

Qoliana is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7265117 Topical brimonidine tartrate formulations that lack chlorine dioxide 19 Aug, 2025
(10 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qoliana's drug page


15. Reclast

Reclast is protected by 5 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7932241
(Pediatric)
Pharmaceutical products comprising bisphosphonates 05 Aug, 2028
(3 years from now)
Active
US7932241 Pharmaceutical products comprising bisphosphonates 05 Feb, 2028
(3 years from now)
Active
US8052987 Method of administering bisphosphonates 27 Oct, 2023
(11 months ago)
Expired
US4939130
(Pediatric)
Substituted alkanediphosphonic acids and pharmaceutical use 02 Mar, 2013
(11 years ago)
Expired
US4939130 Substituted alkanediphosphonic acids and pharmaceutical use 02 Sep, 2012
(12 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Reclast's drug page


16. Ritalin La

Ritalin La is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6228398 Multiparticulate modified release composition 01 Nov, 2019
(4 years ago)
Expired
US5837284 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired
US6635284 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired
US7431944 Delivery of multiple doses of medications 04 Dec, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ritalin La's drug page


17. Timolol Maleate

Timolol Maleate is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6174524
(Pediatric)
Gelling ophthalmic compositions containing xanthan gum 26 Sep, 2019
(5 years ago)
Expired
US6174524 Gelling ophthalmic compositions containing xanthan gum 26 Mar, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Timolol Maleate's drug page


18. Travatan Z

Travatan Z is protected by 5 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8268299 Self preserved aqueous pharmaceutical compositions 13 Oct, 2029
(4 years from now)
Active
US8323630 Self-preserved aqueous pharmaceutical compositions 20 Sep, 2027
(2 years from now)
Active
US8388941 Self preserved aqueous pharmaceutical compositions 20 Sep, 2027
(2 years from now)
Active
US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension 02 Dec, 2014
(9 years ago)
Expired
US5510383 Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension 03 Aug, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Travatan Z's drug page


19. Vivelle-dot

Vivelle-dot is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5656286 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Aug, 2014
(10 years ago)
Expired
US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration 07 Jan, 2014
(10 years ago)
Expired
US5474783 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012
(11 years ago)
Expired
US5958446 Solubility parameter based drug delivery system and method for altering drug saturation concentration 12 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vivelle-dot's drug page


20. Zofran

Zofran is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5854270
(Pediatric)
Oral compositions containing ondansetron 20 May, 2016
(8 years ago)
Expired
US5854270 Oral compositions containing ondansetron 20 Nov, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zofran's drug page


21. Zofran Odt

Zofran Odt is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5955488
(Pediatric)
Freeze-dried compositions 14 May, 2016
(8 years ago)
Expired
US6063802
(Pediatric)
Ondansetron freeze-dried dosage form compositions for oral administration 14 May, 2016
(8 years ago)
Expired
US5955488 Freeze-dried compositions 14 Nov, 2015
(8 years ago)
Expired
US6063802 Ondansetron freeze-dried dosage form compositions for oral administration 14 Nov, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zofran Odt's drug page


Sandoz News

FDA grants approval to Fresenius Kabi for biosimilar of Stelara called Otulfi, announces Pharmaceutical Technology

01 Oct, 2024

Court rejects Regeneron's request to stop production of generic version of popular eye medication

24 Sep, 2024

Sandoz to Introduce First Generic GLP1 Drug in Canadian Market by 2026 - SWI swissinfo.ch

04 Sep, 2024

Sandoz Sets to Release First Generic GLP1 Drug in Canada in 2026, as Reported by BNN Bloomberg

03 Sep, 2024

See More